About AQEMIA
AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline.
Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology.
Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data.
We already delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies. Our most advanced programs are currently in vivo optimization.
About the team you’ll join:
We are seeking an R&D Team Manager to lead and scale our drug discovery team.
You will report directly to Nicolas, the Head of Drug Discovery Platform at Aqemia. Nicolas oversees our largest team: the Platform, which comprises 30 individuals at Aqemia.
We currently have three distinct management positions available, and your assignment will be based on your skills and expertise. Each of these teams is composed of three to five mid-level cross-functional professionals specializing in areas such as Machine Learning or Computational Chemistry.
The objectives of the three different teams are as follows:
1- Identify the most relevant chemical starting points to kick-start many drug discovery programs.
2- Expand chemical series toward highly potents molecules and enable Drug Discovery programs to start studying cell efficacy.
3- Optimize highly potents molecules to make them active in cell-lines and then demonstrate in-vivo efficacy.
Your role as a R&D team Manager at Aqemia:
As a R&D Team Manager, you will be responsible for planning, strategizing, and executing complex problem-solving initiatives. Your role will involve breaking down intricate problems into solvable tasks, fostering a culture of scientific rigor, and translating business needs into pragmatic solutions.
Why Join Us ?
At AQEMIA, we work for a mission: joining us means having your own impact on changing the way drugs are discovered, and helping to shape the direction of our fast-growing company and team.
Expanding Drug Discovery Pipeline : Focused on critical diseases like immuno-oncology, with in vivo proof of concept/patent stage programs. Collaborations with top Pharma, including a $140M Sanofi deal.
Interdisciplinary Team : brilliant talent from tech and life sciences.
Experienced Leadership : Founders with 15+ years at ENS, Oxford, Cambridge, and BCG.
DeepTech Recognition: Part of French Tech 120 and France 2030.
Prime Location : Based in central Paris with the possibility of 2 remote days per week.
International Environment : English-speaking team with relocation support and French lessons if needed.
Strong Financial Backing : $60M raised from leading European deeptech investors
These companies are also recruiting for the position of “Executive”.